ZOLL Medical Corporation Acquires Respicardia, Inc.
April 12, 2021
ZOLL Medical Corporation, an Asahi Kasei company, acquired Respicardia, Inc., the developer of the implantable remēde® System for treating moderate to severe Central Sleep Apnea (CSA). The acquisition brings Respicardia’s FDA-approved neurostimulation technology and employees into ZOLL’s cardiac and respiratory care portfolio to expand treatment capabilities and global reach.
- Buyers
- ZOLL Medical Corporation
- Targets
- Respicardia, Inc.
- Industry
- Medical Devices
- Location
- Minnesota, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
ResMed Completes Acquisition of Noctrix Health for $340 Million
June 1, 2026
Medical Devices
ResMed completed its acquisition of Noctrix Health, a medical device company developing wearable therapeutics for chronic neurological disorders. The deal expands ResMed’s clinical sleep health portfolio with Noctrix’s Nidra Tonic Motor Activation (TOMAC) therapy for moderate-to-severe Restless Legs Syndrome (RLS), with Noctrix becoming a wholly owned subsidiary. The acquisition was previously announced as a definitive merger agreement to acquire Noctrix for $340 million, expected to close on or around June 1, 2026.
-
Resonetics Completes Acquisition of Resolution Medical
January 27, 2026
Healthcare Services
Resonetics completed its acquisition of Resolution Medical, expanding its end-to-end design, finished-device, and sub-assembly capabilities for interventional, structural heart, and neuromodulation markets. The deal integrates Resolution Medical’s biosimulation, NPI, and cleanroom assembly expertise with Resonetics’ AGILE Product Development group and advanced manufacturing capabilities.
-
Resideo Technologies Acquires Snap One for $1.4B
April 15, 2024
Logistics & Distribution
Resideo Technologies agreed to acquire Snap One Holdings for $10.75 per share in cash, valuing the transaction at approximately $1.4 billion including net debt. Snap One will integrate into Resideo's ADI Global Distribution business to expand Resideo's smart-living product portfolio, proprietary offerings and distribution capabilities; the deal is financed in part by a $500 million perpetual convertible preferred equity investment from Clayton, Dubilier & Rice.
-
Kensington Capital Partners Acquires Resolute Health Corporation Limited
June 3, 2022
Healthcare Services
Kensington Capital Partners (Kensington) has acquired Resolute Health Corporation Limited, a Canada-based provider of obstructive sleep apnea (OSA) testing and treatment. Resolute operates a multi-brand network of clinics across several provinces; the partnership is intended to scale the business and expand geographic reach to provide greater access to OSA diagnosis and therapy.
-
ZOLL Medical Corporation Acquires Itamar Medical Ltd.
December 16, 2021
Medical Devices
ZOLL Medical Corporation, an Asahi Kasei company, has completed the acquisition of Itamar Medical Ltd., a developer of at-home sleep apnea diagnostic devices and digital health solutions. ZOLL acquired all outstanding shares for $1.0333333 per ordinary share (approximately $31 per ADS), and Itamar will be delisted from Nasdaq and TASE and operate as a business division within ZOLL.
-
Picard Medical Acquires SynCardia Systems
September 30, 2021
Medical Devices
Picard Medical, a portfolio company of Hunniwell Lake Ventures, has acquired SynCardia Systems, the global leader in total artificial heart (TAH) technology. The deal brings SynCardia into Picard’s medical-device platform to accelerate product improvements, manufacturing capabilities, clinical support and pursuit of expanded regulatory approvals.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.